Behavioral and Psychological Symptoms of dementia (BPSD)
|
|
- Jasmin Carr
- 5 years ago
- Views:
Transcription
1 Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management Pharmacotherapy Conflicts of interest to declare : none
2 BPSD Symptoms of disturbed perception, thought content, mood or behaviour that frequently occur in patients with dementia (International Consensus Conference on Behavioural Disturbances of Dementia, 1996) For more information:
3 BPSD - how common is it? BPSD is virtually universal among dementia patients, at some stage in their illness Affective symptoms are more common in earlier stages Agitation & psychosis are more common in later stages BPSD contibutes greatly to carer burden, and often leads to residential placement
4 The person-centred approach BPSD can be: communicating an unmet need a symptom of a wider problem Empathy, patience, tolerance & understanding are key Terminology is important BPSD is a product of the illness; not helpful to view as bad
5 Psychiatric symptoms - 1 Delusions (~30%) - theft, infidelity, persecution, abandonment, phantom boarder Misidentification (~30%) - own home, relatives, TV, mirror image Hallucinations (~25%) - especially visual
6 Psychiatric symptoms - 2 Depression (~20-40%) - often atypical, easily missed - pseudodementia Anxiety states (up to 40%) - situational or pervasive, - catastrophic reactions, panic, compulsions - new onset strongly implies depression
7 Behavioural symptoms -1 Verbal behaviour constant requests for attention or succour verbal negativism Repetitious phrases or questions repeated yelling disinhibited/tactless remarks
8 Behavioural symptoms -2 Physical behaviours general restlessness, agitation, sundowning pacing, trailing or intrusiveness inappropriate dressing/undressing trying to get to a different place ( wandering ) handling/hoarding things inappropriately sleep disruption disinhibition/poor impulse control
9 Behavioural symptoms - 3 Aggressive behaviour Swearing or cursing Verbal threats Resistiveness to cares Punching, slapping, biting, kicking
10 Behavioural symptoms - 4 Negative symptoms Apathy, inactivity, Daytime drowsiness Social withdrawal Loss of conversational ability
11 Incidence influenced by Neurobiologic factors (neurochemical, neuropathological) Psychological factors (premorbid personality, response to stress) Environmental factors (physical, social)
12 Medical Common triggering or exacerbating factors Occult illness, delirium, pain, urinary/fecal retention, visual/hearing problems, drugs/alcohol, medication toxicity Psychological Depression, psychosis, panic, grief, frustration, reactivation of old memories, boredom, difficulty communicating Physiological Cold, wet, hunger, thirst, noise, tiredness, discomfort Environmental Lack of orienting cues, lack of space, restraint, upset by other residents or style of caregiving, disruption of familiar routines, cultural or religious insensitivity Procedures Dressing, toileting, bathing, turning, catheterisation, cleaning teeth, etc
13 Helping BPSD Clarify and quantify the problem(s) Does it really matter? Involve carers Attempt to understand the problem(s) : specific cognitive deficits underpinning medical &/or psychiatric factors environmental & psychosocial factors unmet human needs Non-pharmacological management Drug treatment
14 Aids to assessment Behaviour charts : A= Antecedent B= Behaviour C= Consequences (Rating scales)
15 Non-pharmacological measures Simple, pragmatic remedies can sometimes be strikingly effective (eg attention to basic physiologic needs) Reassurance, Re-orientation, Re-direction Effective communication (simple, repeated, clear, unhurried; choices not orders; avoid arguing or scolding; eye contact, touch; use humour and affirmation;) Adjust physical/social environment (try to be flexible and creative)
16 Specific activities or therapies Reminiscence Validation therapy Behaviour modification Cued recall Music therapy and dance Motivational therapy Doll therapy Pet therapy
17 Principles of pharmacological treatment Only when BPSD is causing moderate or severe distress Not all target symptoms are appropriate for drug treatment Sedation for emergencies only Choice of drug determined by the predominant psychiatric syndrome pertaining (psychosis, depression, anxiety) Onset of therapeutic benefit usually delayed
18 Pharmacotherapy Reviews indicate modest benefits and large placebo responses Antipsychotics Antidepressants Cholinesterase inhibitors (Benzodiazepines)
19 Antipsychotics Potentially useful for: hallucinations, paranoid delusions; aggression (sometimes) Useless for: wandering, urination problems, calling out (unless driven by psychosis), social withdrawal, apathy, intruding into others personal space
20 Antipsychotics risperidone mg bd haloperidol mg bd quetiapine mg per day aripiprazole 10mg per day olanzapine mg per day (clozapine mg per day)
21 Antipsychotics adverse effects Increased risk of stroke and death Parkinsonism Falls Sedation Dulling, less able to participate Tardive dyskinesia Constipation
22 Antipsychotics good prescribing Start low, go slow; increase not more often than weekly Time dose according to behaviour occurrence Monitor for side effects REVIEW regularly; if it doesn t help, STOP! If it does help, review at least 3 monthly Attempt to taper it off beware the eternal prescription
23 Antidepressants citalopram / escitalopram sertraline mirtazapine moclobemide Potentially helpful for: dysphoria, anxiety, agitation, sleep More likely to try this if PH depression
24 Cholinesterase inhibitors donepezil rivastigmine (unsubsidised) Potentially useful for : apathy, hallucinations, agitation
BEHAVIORAL PROBLEMS IN DEMENTIA
BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and
More informationManagement of Behavioral Problems in Dementia
Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of
More informationRecognition and Management of Behavioral Disturbances in Dementia
Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic
More informationPsychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD
Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationBEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA
BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA Unmet needs What might be your behavioural response to this experience? Content Definition What are BPSD? Prevalence How common are they? Aetiological
More informationDrugs used to relieve behavioural and psychological symptoms in dementia
alzheimers.org.uk Drugs used to relieve behavioural and psychological symptoms in dementia People with dementia may develop behavioural and psychological symptoms including restlessness, aggression, delusions,
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationPSYCHOTROPIC SOLUTIONS
PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia
More informationMental Health Issues in Nursing Homes. I m glad you asked.
Mental Health Issues in Nursing Homes I m glad you asked. I m glad you asked Susan Wehry, M.D. Associate Professor of Psychiatry, College of Medicine, University of Vermont Consultant, State of Vermont
More informationPresented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD
Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate
More informationAssessment and management of behavioral and psychological symptoms of dementia
Assessment and management of behavioral and psychological symptoms of dementia Helen C Kales, 1 2 3 Laura N Gitlin, 4 5 6 Constantine G Lyketsos 7 1 Section of Geriatric Psychiatry, Department of Psychiatry,
More informationOptimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches
Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehab Institute, UHN Learning objectives Recognize
More informationWHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by
WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together Presented by Our agenda for today Understanding behavioral symptoms in people living with dementia Briefly review key strategies
More informationCognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics
Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also
More information9/11/2012. Clare I. Hays, MD, CMD
Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management
More informationAddressing Difficult Behaviors in Dementia
Addressing Difficult Behaviors in Dementia GEORGE SCHOEPHOERSTER, MD GERIATRICIAN GENEVIVE/CENTRACARE CLINIC Objectives By the end of the session, you will be able to: 1) Explain the role of pain management
More informationPsychotropic Medication. Including Role of Gradual Dose Reductions
Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which
More informationMODULE III Challenging Behaviors
Mental Health Ombudsman Training Manual Advocacy and the Adult Home Resident MODULE III Challenging Behaviors S WEHRY 2004 Objectives: Part One Describe principles of communication Describe behavior as
More informationPSYCHOTROPIC SOLUTIONS
PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Hello everyone. Today we will be discussing the
More informationOrganization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit
Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed
More informationLewy Body Disease. Dementia Education for the First Responder July 27, 2017
Lewy Body Disease Dementia Education for the First Responder July 27, 2017 Dylan Wint, M.D. NV Energy Chair for Brain Health Education Cleveland Clinic Lou Ruvo Center for Brain Health OUTLINE Lewy body
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationPharmacological Treatment of Aggression in the Elderly
Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question
More informationManagement of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal
Management of Behavioral Symptoms in Dementia Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Behavioral Symptoms Common & troubling At least one will occur in 61-92% of those with any dementia
More information11/11/2016. Disclosures. Natural history of BPSD. Objectives. Assessment of BPSD. Behavioral Management of Persons with Alzheimer s Disease
Disclosures Behavioral Management of Persons with Alzheimer s Disease Wisconsin Association of Medical Directors November 17, 2016 Art Walaszek, M.D. Professor of Psychiatry UW School of Medicine & Public
More informationCommunity Pharmacy Dementia Audit
Community Pharmacy Dementia Audit Introduction To comply with the NHS contractual requirements associated with the Clinical Governance Essential Service, pharmacy contractors must perform an annual practice
More informationDementia: Managing Difficult Behaviors. No conflicts of interest. Off-label medication use will be discussed during this talk.
Dementia: Managing Difficult Behaviors No conflicts of interest. Off-label medication use will be discussed during this talk. 1 Types of Neurocognitive Disorder Alzheimer s Disease Vascular Frontotemporal
More informationDementia & Delirium: Contents. Behaviours, Symptoms & Integrated Person-Centred Care. You & Your Care Dementia Pg.
Dementia & Delirium: Contents Dementia Pg. 2 Common Types of Dementia Pg. 2 Behavioural & Psychological Symptoms of Dementia (BPSD) Pg. 2 Symptoms of BPSD Pg. 3 Causes of BPSD Pg. 3 Managing BPSD Pg. 3
More informationAlison Charleston 1 st September 2016
Alison Charleston 1 st September 2016 Clinical features of Parkinson s disease Differential diagnosis Management of the motor features Non-motor and neuropsychiatric aspects 100-200 per 100,000 prevalence
More informationTHE BEHAVIOURAL VITAL SIGNS (BVS) TOOL
DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological
More informationDrugs for behavioural and psychological symptoms in dementia
Drugs for behavioural and psychological symptoms in dementia Factsheet 408LP January 2017 People with dementia often develop changes as their condition progresses. These include changes in their behaviour
More informationDEMENTIA AND MEDICATION
DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,
More informationNeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.
ISSNISSN ISSN: 2456-3927 NeuroPharmac Journal Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. Alshahrani www. neuropharmac.com Jan-April 2018, Volume 3, Issue
More informationPharmacologyonline 1: (2009) ewsletter Rosanna Erra. Atypical Antipsychotic Drugs for the Treatment of BPSD. in Subjects with Dementia
Atypical Antipsychotic Drugs for the Treatment of BPSD in Subjects with Dementia Rosanna Erra School of Pharmacy, University of Salerno, Italy ros.erra@libero.it Summary Behavioural and psychological disorders
More informationAntipsychotic Medication in Dementia; The good, the bad and the ugly! Anthony Bainbridge Deputy Director of Nursing Sheffield Health and Social Care
Antipsychotic Medication in Dementia; The good, the bad and the ugly! Anthony Bainbridge Deputy Director of Nursing Sheffield Health and Social Care Different types of antipsychotic medication Antipsychotic
More informationDementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist
Dementia Training Session for Carers By Dr Rahul Tomar Consultant Psychiatrist Dementia in the UK: Facts & Figures National Dementia strategy launched in 2009 800,000 people living with dementia (2012)
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary and Secondary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary and Secondary Care Guidelines for the management of psychological symptoms of Dementia in Primary and
More informationIntroduction to Dementia: Complications
Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:
More informationAppendix N: Research recommendations
Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist
More informationDifficult Behaviors: Managing without Antipsychotics
Difficult Behaviors: Managing without Antipsychotics P R O V I D E D B Y : Requirements Requirements to receive continuing education credit: Attendance at entire event Must sign in & provide email address
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationAntipsychotics for Dementia Under Control or Over-Prescribed?
Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most
More information40% of mild cognitive impairment 60% of patients in early stage of dementia
BPSD Vague and under-researched although described clearly by Alois Alzheimer Term ratified by 1996 IPA consensus conference Not fully recognised in current diagnostic systems Bypassed by dementia strategy
More informationSession outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review
Dementia 1 Session outline Introduction to dementia Assessment of dementia Management of dementia Follow-up Review 2 Activity 1: Person s story Present a person s story of what it feels like to live with
More informationManaging Challenging Behaviors
Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine & Lorin M. Scher, MD Attending Psychiatrist, HDSA Center of Excellence UC
More informationPharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital
Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital with thanks to Jonathan Cavan for his input Aims Define BPSD and common symptoms
More informationPharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018
Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Mary Ellen Quiceno, MD, FAAN Associate Professor of Neurology UNTHSC Center for Geriatrics 855 Montgomery Street, PCC 4, Ft.
More informationSeniors Helping Seniors September 7 & 12, 2016 Amy Abrams, MSW/MPH Education & Outreach Manager Alzheimer s San Diego
Dementia Skills for In-Home Care Providers Seniors Helping Seniors September 7 & 12, 2016 Amy Abrams, MSW/MPH Education & Outreach Manager Alzheimer s San Diego Objectives Familiarity with the most common
More informationManaging Challenging Behaviors
Managing Challenging Behaviors Barbara J. Kocsis, MD Psychiatry Resident, HDSA Center of Excellence UC Davis School of Medicine In partnership with Drs. Lorin Scher, MD and Vicki Wheelock, MD 1 Our Goal
More informationManaging agitation in dementia using non-pharmacological therapies
Managing agitation in dementia using non-pharmacological therapies Gill Livingston Lynsey Kelly, Elanor Lewis-Holmes, Gianluca Baio, Rumana Omar, Stephen Morris, Nishma Patel, Cornelius Katona, Claudia
More informationDementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE
Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Objectives At the conclusion of the session, participants will be
More informationCambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information
Organic disorders 1 Delirium Based on Delirium by Laura Gage and David K. Conn in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Delirium needs treatment for both its
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationManagement of the Acutely Agitated Long Term Care Patient
Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia
More informationMedication Treatment of Cognitive and Behavioral Symptoms in Dementia
Medication Treatment of Cognitive and Behavioral Symptoms in Dementia Cary J. Kohlenberg, M.D. Medical Director, IPC Research and Independent Psychiatric Consultants Environmental interventions directly
More informationBehavioural and Psychological Symptoms of Dementia (BPSD) in Primary Care
Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary Care Dr. John Puxty Ontario s Ontario s Strategy Strategy for Alzheimer for Disease and Related Dementia: Initiative #2, #2, Physician
More informationManagement of the Behavioral and Psychological Symptoms of Dementia (BPSD)
Management of the Behavioral and Psychological Symptoms of Dementia (BPSD) Soheyla Mahdavian, PharmD, BCGP, TTS Associate Professor of Pharmacy Practice Florida A&M University College of Pharmacy and Pharmaceutical
More informationDelirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us
Delirium Information for patients and relatives Delirium is common Delirium is treatable Relatives can stay to help us What is delirium? Delirium is caused by a disturbance of brain function. It is used
More informationTreatment of behavioral and psychological symptoms of dementia: a systematic review
Psychiatr. Pol. 2016; 50(4): 679 715 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/64477 Treatment of behavioral and psychological symptoms
More informationUp to 90% of people with dementia experience
Focus on CME at the University of Calgary Getting Aggressive with Dementia Adrienne Cohen, MD, BSc, FRCPC Presented at Behaviour Problems in the Elderly, video-audio conference, 2003 Up to 90% of people
More informationANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?
ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? STEPHANIE M. OZALAS, PHARMD, BCPS, BCGP VA MARYLAND HEALTH CARE SYSTEM BALTIMORE, MD DISCLOSURES Off-label use of medications will be
More informationAcross the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs
Across the Spectrum of Dementia Keys to Understanding Behaviours & Anticipating Needs Outline Review current predictions for dementia prevalence, & the implications for future needs Discuss retrogenesis
More information12/17/2012. Unnecessary Drugs
Nursing Home Social Work Webinar Series December 19, 2012 Dr. Robin P. Bonifas, PhD, MSW Arizona State University School of Social Work Importance of familiarity with psychotropic medication regulations.
More informationGERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017
More informationDelirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationRisks of Antipsychotics use In Dementia
AHCA/NCAL Quality Initiative for Assisted Living Webinar Series: Safely Reducing the Off-Label Use of Antipsychotics Risks of Antipsychotics use In Dementia Sanjay P. Singh, MD Chairman & Professor, Department
More informationBeyond the Bath: Leading Dementia Care in Long Term Care
Beyond the Bath: Leading Dementia Care in Long Term Care Wilma Greene MN, CNS Paula Walters, MEd, CNS 1 Define and explain Behavioral and Psychological Symptoms of Dementia (BPSD) Present prevalence of
More informationDiagnosis and Treatment of Alzhiemer s Disease
Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised
More informationThis information explains the advice about supporting people with dementia and their carers that is set out in NICE SCIE clinical guideline 42.
Supporting people with dementia and their carers Information for the public Published: 1 November 2006 nice.org.uk About this information NICEclinicalguidelinesadvisetheNHSoncaringforpeoplewithspe cificconditionsordiseasesandthetreatmentstheyshouldreceive.
More informationDisclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA
Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationHow I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C)
How I Treat Aggression in Outpatients With Dementia C. Omelan MD, FRCP(C) Conflict of Interest I have no potential conflicts of interest to declare Overview Outline the prevalence of aggression Review
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationPsychotropic Strategies Handout Package
Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles
More informationPsychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson
Psychotropic Drug Therapy in Adults with Learning Disability Steve Wilkinson Outline and Aims of the Session Drug use in learning disability Two distinct areas of drug therapy I. Treatment of common psychiatric
More informationHow Aging and Dementia Effect Resident Behaviors
How Aging and Dementia Effect Resident Behaviors November 3, 2011 1:00 2:00 PM EST Webinar Presented by: Alfred W. Norwood, BS, MBA Education Arm of the Carmelite Sisters for the Aged and Infirm Webinar
More informationThe Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003
Focus on CME at Queen s University Focus on CME at Queen s University The Agitated The Older Patient: What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003 Both
More informationDementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP
Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia
More informationOlder People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director
Older People Mental Health - new directorate/new plans Dr Adrian Treloar Clinical director Dementia 700,000 people in the UK currently have dementia; this number is set to double by 2038 1/3 of people
More informationAmanda Adams-Fryatt RN MN Nurse Practitioner WRHA
Amanda Adams-Fryatt RN MN Nurse Practitioner WRHA Discuss the prevalence of BPSD Discuss the etiology of Disruptive Vocalizing Discuss memory and communication Discuss the Needs-Based Models Discuss the
More informationDelirium. Quick reference guide. Issue date: July Diagnosis, prevention and management
Issue date: July 2010 Delirium Diagnosis, prevention and management Developed by the National Clinical Guideline Centre for Acute and Chronic Conditions About this booklet This is a quick reference guide
More informationBest Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care
Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care A Person-Centered Interdisciplinary Approach October 25, 2012 Acknowledgements
More informationAnxiety & Alzheimer s Disease
Anxiety & Alzheimer s Disease Anxiety is a normal feeling that everyone experiences now and again. In some people, however, these feelings can be very strong and persistent. This can interfere with a person's
More informationBehavioural Symptoms of Dementia
Quality Standards Behavioural Symptoms of Dementia Care for Patients in Hospitals and Residents in Long-Term Care Homes Let s make our health system healthier Summary This quality standard addresses care
More informationDementia Care Principles
New CMS Surveyor Guidance: Care & Services for a Resident with Dementia Cat Selman, BS www.thehealthcarecommunicators.com 2015 The Healthcare Communicators, Inc. All rights reserved. Dementia Care Principles
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationAppendix L: Research recommendations
1 L.1 Dementia diagnosis (amyloid PET imaging) recommendation 1 Index Test Reference Test(s) Does amyloid PET imaging provide additional diagnostic value, and is it cost effective, for the diagnosis of
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationPsychiatric and Behavioral Challenges in HD
Psychiatric and Behavioral Challenges in HD Lorin M. Scher, MD Department of Psychiatry and Behavioral Sciences UC Davis School of Medicine June 8 th 2012 1 Disclosure Advisory Board for Lundbeck Inc.
More information10/5/2017. BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in DEMENTIA (BPSD) Dr. Shah MD, MPH Braodlawns Medical Center DISCLOSURE
1 BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in DEMENTIA (BPSD) Dr. Shah MD, MPH Braodlawns Medical Center DISCLOSURE 2 Dr. Shah has no relevant conflicts with commercial interests to disclose. OBJECTIVES 3
More informationNon-Pharmacological Interventions for Persons With Dementia. John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW
Non-Pharmacological Interventions for Persons With Dementia John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW Prevalence3 5.5 million people in the United States are aging with dementia and complex comorbidities
More informationStroke and Behaviour Change
Stroke and Behaviour Change Kathy Baker BA (Psych), BScN, MAL (Health) Mary-Lou Nolte, Ph.D., C. Psych. Objectives Describe relationships among cognition, mood and behaviour change after stroke Describe
More informationCurrent Treatments for Dementia and Future Prospects. James Warner St Charles Hospital, London
Current Treatments for Dementia and Future Prospects James Warner St Charles Hospital, London Dementia Cognitive Non-cognitive (BPSD) Memory orientation language other cognitive abilities praxis planning
More informationPharmacological Management of Dementia-Related Behaviors
Welcomes You To Pharmacological Management of Dementia-Related Behaviors Presented by Brett Lu, MD, PhD Associate Professor of Psychiatry John A. Burns School of Medicine September 5, 2017 10:00 11:00
More information